Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent Mycobacterium tuberculosis K infection

References

• Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–1843.
   PubMed Web of Science ®Google Scholar
• Mortaz E, Adcock IM, Tabarsi P, et al. Interaction of pattern recognition receptors with Mycobacterium tuberculosis. J Clin Immunol. 2015;35:1–10.
   PubMed Web of Science ®Google Scholar
• Thada S, Valluri VL, Gaddam SL. Influence of Toll-like receptor gene polymorphisms to tuberculosis susceptibility in humans. Scand J Immunol. 2013;78:221–229.
   PubMed Web of Science ®Google Scholar
• Flynn JL, Chan J, Triebold KJ, et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med. 1993;178:2249–2254.
   PubMed Web of Science ®Google Scholar
• Wei Z, Wenhao S, Yuanyuan M, et al. A single nucleotide polymorphism in the interferon-gamma gene (IFNG +874 T/A) is associated with susceptibility to tuberculosis. Oncotarget. 2017;8:50415–50429.
   PubMedGoogle Scholar
• Nandi B, Behar SM. Regulation of neutrophils by interferon-gamma limits lung inflammation during tuberculosis infection. J Exp Med. 2011;208:2251–2262.
   PubMed Web of Science ®Google Scholar
• Sasindran SJ, Torrelles JB. Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium? Front Microbiol. 2011;2:2.
   PubMed Web of Science ®Google Scholar
• Redford PS, Murray PJ, O’Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 2011;4:261–270.
   PubMed Web of Science ®Google Scholar
• Beamer GL, Flaherty DK, Assogba BD, et al. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol. 2008;181:5545–5550.
   PubMed Web of Science ®Google Scholar
• Sepehri Z, Kiani Z, Kohan F, et al. Toll-Like Receptor 4 as an Immune Receptor Against Mycobacterium tuberculosis: A Systematic Review. Lab Med. 2019;50:117–129.
   PubMed Web of Science ®Google Scholar
• Tokuda S, Beyer BJ, Frankel WN. Genetic complexity of absence seizures in substrains of C3H mice. Genes Brain Behav. 2009;8::283–9.
   PubMed Web of Science ®Google Scholar
• Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999;162:3749–3752.
   PubMed Web of Science ®Google Scholar
• Suhs KA, Marthaler BR, Welch RA, et al. Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice. MBio. 2011;2:e00094–11.
   PubMed Web of Science ®Google Scholar
• Totemeyer S, Foster N, Kaiser P, et al. Toll-like receptor expression in C3H/HeN and C3H/HeJ mice during Salmonella enterica serovar Typhimurium infection. Infect Immun. 2003;71:6653–6657.
   PubMed Web of Science ®Google Scholar
• Hossain MM, Norazmi MN. Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection–the double-edged sword? Biomed Res Int. 2013;2013:179174.
   PubMed Web of Science ®Google Scholar
• Wynn TA. T(H)-17: a giant step from T(H)1 and T(H)2. Nat Immunol. 2005;6:1069–1070.
   PubMed Web of Science ®Google Scholar
• Kumar S, Sunagar R, Gosselin E. Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants. Front Immunol. 2019;10:1144.
   PubMed Web of Science ®Google Scholar
• Penn-Nicholson A, Tameris M, Smit E, et al. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial. Lancet Respir Med. 2018;6:287–298.
   PubMed Web of Science ®Google Scholar
• Abel B, Thieblemont N, Quesniaux VJ, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol. 2002;169:3155–3162.
   PubMed Web of Science ®Google Scholar
• Branger J, Leemans JC, Florquin S, et al. Van Der Poll T. Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. Int Immunol. 2004;16:509–516.
   PubMed Web of Science ®Google Scholar
• Shim TS, Turner OC, Orme IM. Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2003;83:367–371.
   PubMed Web of Science ®Google Scholar
• Reiling N, Holscher C, Fehrenbach A, et al. Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol. 2002;169:3480–3484.
   PubMed Web of Science ®Google Scholar
• Shin SJ, Lee BS, Koh WJ, et al. Efficient differentiation of Mycobacterium avium complex species and subspecies by use of five-target multiplex PCR. J Clin Microbiol. 2010;48:4057–4062.
   PubMed Web of Science ®Google Scholar
• Kim WS, Kim JS, Cha SB, et al. Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain. Oncotarget. 2016;7:24962–24982.
   PubMed Web of Science ®Google Scholar
• Jeon BY, Kim SC, Eum SY, et al. The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis. Microbes Infect. 2011;13:284–290.
   PubMed Web of Science ®Google Scholar
• Ehlers S, Schaible UE. The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front Immunol. 2012;3:411.
   PubMed Web of Science ®Google Scholar
• Driver ER, Ryan GJ, Hoff DR, et al. Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.. Antimicrob Agents Chemother. 2012;56:3181–3195.
   PubMed Web of Science ®Google Scholar
• Ferwerda B, Kibiki GS, Netea MG, et al. van der Ven AJ. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. Aids. 2007;21:1375–1377.
   PubMed Web of Science ®Google Scholar
• Najmi N, Kaur G, Sharma SK, et al. Human Toll-like receptor 4 polymorphisms TLR4 Asp299Gly and Thr399Ile influence susceptibility and severity of pulmonary tuberculosis in the Asian Indian population. Tissue Antigens. 2010;76:102–109.
   PubMedGoogle Scholar
• Cubillos-Angulo JM, Arriaga MB, Silva EC, et al. Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study. Clin Infect Dis. 2019;69:1027–1035.
   PubMed Web of Science ®Google Scholar
• Xue X, Qiu Y, Jiang D, et al. The association analysis of TLR2 and TLR4 gene with tuberculosis in the Tibetan Chinese population. Oncotarget. 2017;8:113082–113089.
   PubMedGoogle Scholar
• Ioerger TR, Feng Y, Ganesula K, et al. Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories. J Bacteriol. 2010;192:3645–3653.
   PubMed Web of Science ®Google Scholar
• Carmona J, Cruz A, Moreira-Teixeira L, et al. Mycobacterium tuberculosis Strains Are Differentially Recognized by TLRs with an Impact on the Immune Response. PLoS One. 2013;8:e67277.
   PubMedGoogle Scholar
• Han SJ, Song T, Cho YJ, et al. Complete genome sequence of Mycobacterium tuberculosis K from a Korean high school outbreak, belonging to the Beijing family. Stand Genomic Sci. 2015;10:78.
   PubMed Web of Science ®Google Scholar
• Kim WS, Kim JS, Cha SB, et al. Virulence-Dependent Alterations in the Kinetics of Immune Cells during Pulmonary Infection by Mycobacterium tuberculosis.. PLoS One. 2015;10:e0145234.
   PubMedGoogle Scholar
• Ordway D, Henao-Tamayo M, Harton M, et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J Immunol. 2007;179:522–531.
   PubMed Web of Science ®Google Scholar
• Whittaker E, Nicol M, Zar HJ, et al. Regulatory T Cells and Pro-inflammatory Responses Predominate in Children with Tuberculosis. Front Immunol. 2017;8:448.
   PubMed Web of Science ®Google Scholar
• Chackerian AA, Perera TV, Behar SM. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis.. Infect Immun. 2001;69:2666–2674.
   PubMed Web of Science ®Google Scholar
• North RJ. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J Infect Dis. 1995;172:1550–1553.
   PubMed Web of Science ®Google Scholar
• Lowe DM, Demaret J, Bangani N, et al. Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood. Front Immunol. 2018;9:903.
   PubMed Web of Science ®Google Scholar
• Kroon EE, Coussens AK, Kinnear C, et al. Neutrophils: innate Effectors of TB Resistance? Front Immunol. 2018;9:2637.
   PubMed Web of Science ®Google Scholar
• Eum SY, Kong JH, Hong MS, et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest. 2010;137:122–128.
   PubMed Web of Science ®Google Scholar
• Keller C, Hoffmann R, Lang R, et al. Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes. Infect Immun. 2006;74:4295–4309.
   PubMed Web of Science ®Google Scholar
• Dorhoi A, Desel C, Yeremeev V, et al. The adaptor molecule CARD9 is essential for tuberculosis control. J Exp Med. 2010;207:777–792.
   PubMed Web of Science ®Google Scholar
• Zhou J, Nefedova Y, Lei A, et al. Neutrophils and PMN-MDSC: their biological role and interaction with stromal cells. Semin Immunol. 2018;35:19–28.
   PubMed Web of Science ®Google Scholar
• Garg A, Spector SA. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity. J Infect Dis. 2014;209:441–451.
   PubMed Web of Science ®Google Scholar
• Zhang X, Majlessi L, Deriaud E, et al. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity. 2009;31:761–771.
   PubMed Web of Science ®Google Scholar
• Silva BDS, Trentini MM, da Costa AC, et al. Different phenotypes of CD8+ T cells associated with bacterial load in active tuberculosis. Immunol Lett. 2014;160:23–32.
   PubMed Web of Science ®Google Scholar
• Gong JH, Zhang M, Modlin RL, et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun. 1996;64:913–918.
   PubMed Web of Science ®Google Scholar
• Tsiganov EN, Verbina EM, Radaeva TV, et al. Gr-1dimCD11b+ immature myeloid-derived suppressor cells but not neutrophils are markers of lethal tuberculosis infection in mice. J Immunol. 2014;192:4718–4727.
   PubMed Web of Science ®Google Scholar
• Bronte V, Brandau S, Chen SH, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.
   PubMed Web of Science ®Google Scholar
• Bajrami B, Zhu H, Kwak HJ, et al. G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling. J Exp Med. 2016;213:1999–2018.
   PubMed Web of Science ®Google Scholar
• Namuganga AR, Chegou NN, Mubiri P, et al. Suitability of saliva for Tuberculosis diagnosis: comparing with serum. BMC Infect Dis. 2017;17:600.
   PubMed Web of Science ®Google Scholar